Cercare Medical
PrivateLast Round
Early Funding
Feb 18, 2025
Total Funding Raised
$9.82M
Company Overview
Cercare Medical is a medical software company that develops AI-powered perfusion imaging solutions for CT and MRI post-processing to diagnose neurological diseases such as stroke, cancer, and dementia.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Medical Imaging, Healthcare Analytics, Vertical SaaS, Computer Vision
Business Model
B2B
Customer Profile
Subscription SaaS, Usage-Based SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cercare Medical Comps
Public and private peers based on sector, stage, and business model.
Cercare Medical Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Feb 18, 2025 | ||||
| Grant | May 2, 2019 |
Key People
Founding team and executive leadership
Cercare Medical Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council | Grant |
| Smedvig | Early Funding |
| Canica | Early Funding |
| West Hill Capital | Early Funding |
| Bagger-Sørensen Equity A/S | Early Funding |
Cercare Medical Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Cercare Medical's valuation, stock price, and market status.
